The bill would place the Advisory Committee on Immunization Practices (ACIP) in federal law and set rules for its membership, meetings, duties, and public records. ACIP would make vaccine recommendations based on the best available peer-reviewed scientific evidence. The Centers for Disease Control and Prevention Director would generally have to adopt its recommendations or publish an explanation for rejecting them. The bill also sets timelines for reviewing newly licensed vaccines, links ACIP recommendations to vaccine coverage and the Vaccines for Children Program, and requires scientific evidence to support certain changes to the Vaccine Injury Table.
The bill could affect which vaccines are recommended, covered by health plans, or included in the Vaccines for Children Program. It would also require public explanations when federal officials reject ACIP recommendations or take certain actions that conflict with them. The bill does not describe individual requirements to receive vaccines.
The bill authorizes $2.8 million for each fiscal year from 2026 through 2029 for ACIP operations, member compensation and travel, and staff support. It does not specify individual expenses.
No publicly available information.
No publicly available information.